Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
Objectives: Chromosomally mediated AmpC-producing Enterobacteriaceae (CAE) display high susceptibility to fluoroquinolones; minimal clinical data exist supporting comparative clinical outcomes. The objective of this study was to compare treatment outcomes between fluoroquinolone and nonfluoroquinolo...
Main Authors: | Sarah Grace Gunter, Katie E. Barber, Jamie L. Wagner, Kayla R. Stover |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/6/331 |
Similar Items
-
Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study
by: Baptiste Hoellinger, et al.
Published: (2023-09-01) -
Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to <i>Enterobacter</i>, <i>Serratia</i>, and <i>Citrobacter</i> Species
by: Caroline Derrick, et al.
Published: (2020-05-01) -
Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study
by: Lena Herrmann, et al.
Published: (2021-06-01) -
Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study
by: Gilles Vossius, et al.
Published: (2023-09-01) -
Building an International One Health Strain Level Database to Characterise the Epidemiology of AMR Threats: ESBL—AmpC Producing <i>E. coli</i> as An Example—Challenges and Perspectives
by: Sara Perestrelo, et al.
Published: (2023-03-01)